Aortic Stent Grafts Market Report 2026

Aortic Stent Grafts Market Overview

• Aortic Stent Grafts market size has reached to $3.59 billion in 2025 • Expected to grow to $5.3 billion in 2030 at a compound annual growth rate (CAGR) of 7.9% • Growth Driver: Rising Cardiovascular Diseases Drive Growth In The Aortic Stent Graft Market • Market Trend: Advancements in Aortic Stent Graft Systems • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Aortic Stent Grafts Market?

Aortic stent grafts refer to medical devices used to reinforce a weakened section of the aorta, the main blood vessel in the body. They consist of a fabric tube (graft) supported by a metal mesh (stent) and are inserted via a minimally invasive procedure to treat aneurysms or other conditions affecting the aorta. The main products of aortic stent grafts are abdominal aortic stent grafts and thoracic aortic stent grafts. An abdominal aortic stent graft is a medical device used to treat an abdominal aortic aneurysm by reinforcing the weakened vessel wall and preventing potential rupture. These devices are utilized across different types such as abdominal aortic aneurysms, and thoracic aortic aneurysms by various end users, including hospitals, ambulatory surgical centers or outpatient surgical centers, and others.

What Is The Aortic Stent Grafts Market Growth Forecast?

The aortic stent grafts market size is expected to see strong growth in the next few years. It will grow to $5.3 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing procedural volumes in ambulatory and outpatient surgical centers, rising demand for hybrid and advanced stent graft systems, expansion of screening programs for aortic aneurysm detection, growing investments in minimally invasive vascular therapy, increasing focus on reducing postoperative complications and hospital stay. Major trends in the forecast period include increasing preference for minimally invasive endovascular repair over open aortic surgery, growing clinical adoption of modular and customizable aortic stent graft designs, rising demand for next-generation graft materials offering greater flexibility and durability, expanding utilization of stent grafts in complex abdominal and thoracic aneurysm cases, increasing shift toward early aneurysm intervention to reduce rupture risk.

Global Aortic Stent Grafts Market Segmentation

1) By Product: Abdominal Aortic Stents Graft, Thoracic Aortic Stents Graft 2) By Indication: Abdominal Aortic Aneurysms, Thoracic Aortic Aneurysms 3) By End User: Hospitals, Ambulatory Surgical Centers Or Outpatient Surgical Centers, Other End-Users Subsegments: 1) By Abdominal Aortic Stent Graft: Endovascular Aneurysm Repair (EVAR) Stent Grafts, Aortic Aneurysm Stent Grafts 2) By Thoracic Aortic Stent Graft: Thoracic Endovascular Aortic Repair (TEVAR) Stent Grafts, Hybrid Aortic Stent Grafts

What Is The Driver Of The Aortic Stent Grafts Market?

The rise in cardiovascular diseases propels the growth of the aortic stent graft market going forward. The increase in cardiovascular disease cases is primarily due to lifestyle factors such as poor diet, lack of exercise, smoking, and rising obesity rates. Aortic stent grafts are used in cardiovascular disease to repair and reinforce weakened or damaged sections of the aorta, particularly in cases of aneurysms. For instance, in January 2024, according to the British Heart Foundation, a UK-based cardiovascular research charity, coronary heart disease (CHD) was a major cause of mortality in the UK, responsible for approximately 68,000 deaths annually. This translates to an average of 190 deaths per day, or one death roughly every eight minutes. In the UK, coronary heart disease accounts for the deaths of one in eight men and one in 14 women. Therefore, the rise in cardiovascular diseases is driving the growth of the aortic stent graft industry.

Key Players In The Global Aortic Stent Grafts Market

Major companies operating in the aortic stent grafts market are Medtronic plc, W.L. Gore & Associates Inc, Terumo Corporation, Cook Medical Inc, Endologix Inc, Lombard Medical Ltd, MicroPort Scientific Corporation, Jotec GmbH, Braile Biomédica, Merit Medical Systems Inc, Endospan Ltd, Lifetech Scientific (Shenzhen) Co Ltd, Biomerics LLC, Bentley InnoMed GmbH, Trivascular Inc, Abbott Laboratories, Becton Dickinson and Company, Biotronik SE & Co KG, Altura Medical Inc, S&G Biotech Inc

Global Aortic Stent Grafts Market Trends and Insights

Major companies operating in the aortic stent graft market are focused on developing advanced products, such as stent-graft system with improved stability, flexibility, and reduced complication risks. A stent-graft system refers to a medical device used in endovascular procedures to treat aneurysms, consisting of a stent for support and a graft to reinforce the vessel wall. For instance, in August 2024, Terumo India, an India-based medical device company, launched TREO Abdominal Stent-graft system. The TREO Abdominal Stent-Graft System is an advanced endovascular device designed for treating infrarenal abdominal aortic aneurysms, offering features like in situ limb adjustability, enhanced sealing, and robust fixation for improved stability and long-term patient outcomes.

What Are Latest Mergers And Acquisitions In The Aortic Stent Grafts Market?

In December 2023, Tekni-Plex Inc., a US-based healthcare company, acquired Seisa Medical for an undisclosed amount. The acquisition strategically bolstered TekniPlex Healthcare's expertise and capabilities in medical materials science and process technologies, particularly enhancing its platform for minimally invasive and interventional therapy devices. Seisa Medical is a US-based medical device manufacturer specializing in aortic stent grafts and valve components.

Regional Outlook

North America was the largest region in the aortic stent grafts market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Aortic Stent Grafts Market?

The aortic stent grafts market consists of sales of tube aortic stent grafts, bifurcated aortic stent grafts, and aorto-uniiliac aortic stent grafts. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.